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Lung masses are usually suspected to represent a malignant 
process, especially if larger in size than 3 cm. Clinicians rely on 
radiologic characteristics of the mass to direct their diagnostic 
approach.1–3 Positron emission tomography (PET) or inte-
grated computed tomography and PET (PET/CT), when 
available, is often considered in the evaluation of lung nodules 
and masses. The positive predictive value of a positive PET 
scan exceeds 80%.4 However, a positive PET scan can also be 
associated with inflammatory masses or pulmonary sarcoido-
sis.5,6 The most common initial presentations of pulmonary 
sarcoidosis in adults are bilateral hilar adenopathy or reticulo-
nodular opacities. Although the initial presentation of sar-
coidosis as lung nodules is not uncommon, it rarely presents as 
large lung mass. We report a case of pulmonary sarcoidosis pre-
senting with initial presentation as a lung mass.
Case Report
A 39-year-old African-American woman with a history of 
ulcerative colitis and tobacco abuse was referred for pulmonary 
consultation for atypical chest pain and abnormal chest x-ray 
(CXR). Her symptoms started 3 months prior to the presenta-
tion and her review of systems was unrevealing except for a 
decrease in appetite but without weight loss. Her physical exam-
ination was essentially normal and she had no lymphadenopathy 
or skin lesions. Initial CXR (Figure 1) found bilateral hilar ade-
nopathy. Therefore, a chest CT scan was done which found a 
concerning mass. Therefore, a PET/CT scan of the chest 
was done and found mediastinal and hilar lymphadenopathy 
(Figure 2) and a right lower lobe lung mass (Figure 3) measured 
4 cm × 3 cm mass all with significant fluorodeoxyglucose uptake. 
Pulmonary function testing was performed and interpreted as 
follows: no defects, normal diffusion, and minimal air trapping. 
A CT-guided biopsy of the mass was consistent with nodular, 
noncaseous granulomas with background fibrous histiocytic 
infiltration and chronic inflammatory cells in the right lower 
lung. Based on these findings, the patient underwent video-
assisted thoracoscopic surgery that revealed noncaseating granu-
lomas consistent with sarcoidosis. Acid-fast bacilli stain, fungal, 
and tissue cultures were negative. A bronchoalveolar lavage was 
not performed. A diagnosis of sarcoidosis was made based on 
pathologic and radiologic evidence. The patient’s symptoms 
resolved spontaneously without systemic glucocorticoids.
Discussion
Sarcoidosis is uncommon with an unknown etiology. In North 
America, the incidence of sarcoidosis is highest among black 
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Figure 1. Portable chest x-ray. Bilateral hilar adenopathy.
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women, whereas in Europe, it is highest among white women. 
Age of onset is between 30 and 45 years of age.7 Typically, the 
diagnosis is straightforward based on pathognomonic signs 
and symptoms. But an atypical presentation often beguiles the 
medical community and can lead to misdiagnosis. Herein, we 
present an atypical case of sarcoidosis as a lung mass with no 
extrapulmonary manifestations.
Diagnosis of sarcoidosis requires 3 elements: (a) radio-
graphic and clinical findings consistent with sarcoidosis, (b) 
exclusion of diseases that present similarly, and (c) biopsy of 
the most accessible lesion, demonstrating noncaseating gran-
ulomas on histopathology.8 Sarcoidosis can present with 
atypical findings on chest radiography and CT scanning of 
nodules (<3 cm) or masses (>3 cm) that resemble primary or 
metastatic cancer.9 Radiographic nodules measure from 1 to 
5 cm in diameter that typically consist of coalescent granulo-
mas.10 These nodules usually tend to be peripheral. Imaging 
also can consist of bilateral hilar and mediastinal nodal 
enlargement, which is frequently seen in approximately 75% 
of the patients.11 Despite these criteria, sarcoidosis is an 
everlasting diagnostic challenge.
Nodular sarcoidosis is an uncommon form of sarcoidosis 
and is prevalent in 2.4% to 4% of cases.12 The first case 
of nodular sarcoidosis was reported by McCord and 
Hyman in 1952 with multiple bilateral nodules imitating 
metastatic disease.13 Most of the patients with nodular 
sarcoidosis are African-American women between 20 and 
40 years of age.14
The spontaneous resolution of the disease is common; how-
ever, up to 10% of the patients can progress to respiratory 
impairment and organ failure. There are no established criteria 
to determine the indications of treatment. The treatment is 
based on severity of symptoms, evidence of impairment in lung 
function, and disease with extensive fibrosis and bullae forma-
tion.15 Oral glucocorticoids are the most commonly used med-
ication in the treatment of sarcoidosis. Other alternative 
therapies such as immunosuppressive and cytotoxic agents 
have been suggested, but there is limited evidence regarding 
Figure 2. Positron emission tomography with computed tomographic 
(PET/CT) scan of mediastinal and hilar lung region. (A) Chest CT 
exhibiting mediastinal and hilar lymphadenopathy, (B) PET scan 
exhibiting uptake in mediastinal and hilar lymph nodes, and (C) fusion 
scan exhibiting uptake in mediastinal and hilar lymph nodes.
Figure 3. Positron emission tomography with computed tomographic 
(PET/CT) scan of lower lung fields. (A) Chest CT exhibiting a large right 
pleural density measured to be 4 cm × 3 cm, (B) PET scan exhibiting 
uptake in a large right pleural density, and (C) fusion scan exhibiting 
uptake in a large right pleural density.
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efficacy of these agents. Nodular sarcoidosis presenting as lung 
mass is exceedingly rare. Most of the identified patients are 
women and smokers. These solitary masses are believed to be a 
coalescence of smaller nodules and prove to be even more mis-
leading and suggestive of a primary cancer. Patients with nodu-
lar sarcoidosis have a favorable prognosis with significant 
improvement in radiographic findings with systemic 
corticosteroids.16
Author Contributions
AJS, NKS, AS, and MT contributed substantially to the 
authorship of this case report. AS and MT were directly 
involved in the patient’s care.
RefeRenCes
 1. Tanner NT, Aggarwal J, Gould MK, et al. Management of pulmonary nodules 
by community pulmonologists: a multicenter observational study. Chest. 
2015;148:1405–1414. doi:10.1378/chest.15-0630.
 2. Gould MK, Tang T, Liu IL, et al. Recent trends in the identification of inciden-
tal pulmonary nodules. Am J Respir Crit Care Med. 2015;192:1208–1214. 
doi:10.1164/rccm.201505-0990OC.
 3. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nod-
ule. N Engl J Med. 2003;348:2535–2542.
 4. Bar-Shalom R, Kagna O, Israel O, Guralnik L. Noninvasive diagnosis of solitary 
pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose 
avidity on positron emission tomography/computed tomography. Cancer. 
2008;113:3213–3221. doi:10.1002/cncr.23928.
 5. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of 
positron emission tomography for diagnosis of pulmonary nodules and mass le-
sions: a meta-analysis. JAMA. 2001;285:914–924.
 6. Chun EJ, Lee HJ, Kang WJ, et al. Differentiation between malignancy and inflamma-
tion in pulmonary ground-glass nodules: the feasibility of integrated (18)F-FDG 
PET/CT. Lung Cancer. 2009;65:180–186. doi:10.1016/j.lungcan.2008.11.015.
 7. Hamzeh N. Sarcoidosis. Med Clin N Am. 2011;95:1223–1234. doi:10.1016/j.
mcna.2011.08.004.
 8. Hunninghake GW, Costabel U, Ando M, et al. Statement on sarcoidosis. 
Joint statement of the American Thoracic Society (ATS), the European 
Respiratory Society (ERS) and the World Association of Sarcoidosis and 
Other Granulomatous Disorders (WASOG) adopted by the ATS Board of 
Directors and by the ERS Executive Committee, February 1999. Am J Respir 
Crit Care Med. 1999;160:736–755.
 9. Kawar E, Saraf SY, Braman SS, Healey TT. Nodular pulmonary sarcoidosis. 
Med Health R I. 2012;95:139–140.
 10. Ma Y, Gal A, Koss MN. The pathology of pulmonary sarcoidosis: update. Semin 
Diagn Pathol. 2007;24:150–161.
 11. Naidich DP, Srichai MB, Krinsky GA. Computed Tomography and Magnetic 
Resonance of the Thorax. Lippincott Williams & Wilkins; 2007.
 12. Malaisamy S, Dalal B, Bimenyuy C, Soubani A. The clinical and radiologic fea-
tures of nodular pulmonary sarcoidosis. Lung. 2008;187:9–15. doi:10.1007/
s00408-008-9118-2.
 13. Nakamura H, Kashiwabara K, Watanabe T, Yagyu H, Kiguchi T, Matsuoka K. 
Sarcoidosis with multiple nodular shadows in bilateral lung fields. Intern Med. 
1995;34:1144–1145. doi:10.2169/internalmedicine.34.1144.
 14. Shahzad H, Ur-Rehman S, Fatima K, Sharif N, Zubairi A. Case series and lit-
erature review of multiple nodular sarcoidosis. BMC Res Notes. 2013;6:394. 
doi:10.1186/1756-0500-6-394.
 15. Sharma OP. Pulmonary sarcoidosis and corticosteroids. Am Rev Respir Dis. 
1993;147:1598–1600.
 16. Romer FK. Sarcoidosis with large nodular lesions simulating pulmonary metas-
tases. An analysis of 126 cases of intrathoracic sarcoidosis. Scand J Respir Dis. 
1977;58:11–16.
